Galantamine Tablet, Film Coated
Product Images NDC 51407-906

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Galantamine (NDC 51407-906). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-906-60ol (Galantamine 4 mg)

FDA Label Image

51407-907-60ol (Galantamine 8 mg)

51407-907-60ol (Galantamine 8 mg)
This text contains information about Galantamine tablets with the NDC code 51407-807-60. It includes instructions to dispense in a light-resistant container, store at 25°C with excursions permitted, and keep out of reach of children. The tablets are also marked for prescription use only and are marketed by GSMS, Incorporated.*
FDA Label Image

51407-908-60ol (Galantamine 12 mg)

51407-908-60ol (Galantamine 12 mg)
This text provides information about a medication called Pyridoxine USP Tablets, with a dosage of 12 mg. It includes guidance on dispensing and storage in a light-resistant container, away from children, at a recommended temperature range. The medication is presented in a pack of 60 tablets and is produced by GSMS, Incorporated in Camarillo, CA, USA. This text is intended for prescription use only.*
FDA Label Image

Chemical Structure (Galantamine 01)

FDA Label Image

Image Description (Galantamine 02)

FDA Label Image

Image Description (Galantamine 04)

FDA Label Image

Image Description (Galantamine 05)

FDA Label Image

Image Description (Galantamine 06)

FDA Label Image

Image Description (Galantamine 07)

FDA Label Image

Image Description (Galantamine 08)

Image Description (Galantamine 08)
This text mentions a treatment plan of 26 weeks for a condition labeled as "d4t." It also references "Boosyy ul" and a phone number.*
FDA Label Image

Image Description (Galantamine 09)

FDA Label Image

Image Description (Galantamine 10)

FDA Label Image

Image Description (Galantamine 11)

FDA Label Image

Image Description (Galantamine 12)

FDA Label Image

Image Description (Galantamine 13)

Image Description (Galantamine 13)
Not available.*
FDA Label Image

Figure2 (Galantamine03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.